OUR BUSINESS

CHIEF EXECUTIVE OFFICER'S REVIEW

The old adage that “time flies” could not be truer as I reflect on the 2021/2022 year that has just passed. The year under review marked my first full year as SANBS Chief Executive Officer (CEO).  It has been a very busy and eventful year, with the SANBS team once again going the extra mile to achieve our purpose of being “Trusted to save lives”.

Ravi Reddy, CHIEF EXECUTIVE OFFICER

OUR BUSINESS

CHIEF EXECUTIVE OFFICER'S REVIEW

The old adage that “time flies” could not be truer as I reflect on the 2021/2022 year that has just passed. The year under review marked my first full year as SANBS Chief Executive Officer (CEO).  It has been a very busy and eventful year, with the SANBS team once again going the extra mile to achieve our purpose of being “Trusted to save lives”.

Ravi Reddy, CHIEF EXECUTIVE OFFICER

Introduction

The Covid-19 pandemic impacted our staff and operational activities throughout the year, particularly in November and December of 2021 with the Omicron variant. We continued to monitor our environment, adapted how we work and made tweaks to our business model to ensure a safe environment for donors and staff while maintaining our supply of blood products to meet demand.

Introduction

The Covid-19 pandemic impacted our staff and operational activities throughout the year, particularly in November and December of 2021 with the Omicron variant. We continued to monitor our environment, adapted how we work and made tweaks to our business model to ensure a safe environment for donors and staff while maintaining our supply of blood products to meet demand.

Leadership changes

There were also a number of new executive appointments during 2021/2022. Dr Karin van den Berg was appointed as Medical Director in May 2021. In addition, we revisited our targeted operating model and, based on the growing complexity of the core value chain, it was decided that the vacant Chief Operations Officer (COO) role was to be replaced by two executive roles, with one role focusing on Donor Services and Corporate Marketing and the other role focusing on Transfusion Medicine and Technical Services (Blood Processing, Testing, Transport Logistics and Issuing of Blood). In November, Ms Siemi Prithvi Raj was appointed as Executive, Transfusion Donor Services and Marketing and Dr Marion Vermeulen was appointed as Executive, Transfusion Medicine and Technical Services. Both Siemi and Marion have extensive experience in Blood Transfusion and served in Senior Manager positions prior to their appointment. Ms Tshepi Maesela, our Chief Financial Officer (CFO), left SANBS in October 2021 after four years of service and I would like to thank Tshepi for her contribution to SANBS. Ms Rianda Kruger was appointed as Acting CFO in October 2021. I would also like to thank Rianda for her stepping into this role and for her contribution.

Leadership changes

There were also a number of new executive appointments during 2021/2022. Dr Karin van den Berg was appointed as Medical Director in May 2021. In addition, we revisited our targeted operating model and, based on the growing complexity of the core value chain, it was decided that the vacant Chief Operations Officer (COO) role was to be replaced by two executive roles, with one role focusing on Donor Services and Corporate Marketing and the other role focusing on Transfusion Medicine and Technical Services (Blood Processing, Testing, Transport Logistics and Issuing of Blood). In November, Ms Siemi Prithvi Raj was appointed as Executive, Transfusion Donor Services and Marketing and Dr Marion Vermeulen was appointed as Executive, Transfusion Medicine and Technical Services. Both Siemi and Marion have extensive experience in Blood Transfusion and served in Senior Manager positions prior to their appointment. Ms Tshepi Maesela, our Chief Financial Officer (CFO), left SANBS in October 2021 after four years of service and I would like to thank Tshepi for her contribution to SANBS. Ms Rianda Kruger was appointed as Acting CFO in October 2021. I would also like to thank Rianda for her stepping into this role and for her contribution.

SANBS celebrates 21 years

The end of March 2022 marked a significant milestone for SANBS as it celebrated the 21st anniversary of the establishment of SANBS on 1 April 2001. SANBS was formed following the amalgamation of seven regional blood services, except for the Western Cape province, which retained its own blood service. Many staff, including myself, have been part of this 21-year journey of SANBS and, like with any family or organisation, there have been both challenges and significant achievements.  A key challenge in the early years was taking into consideration different cultures, practises, procedures and systems, and looking for best practice to develop a roadmap for “One SANBS”.

SANBS celebrates 21 years

The end of March 2022 marked a significant milestone for SANBS as it celebrated the 21st anniversary of the establishment of SANBS on 1 April 2001. SANBS was formed following the amalgamation of seven regional blood services, except for the Western Cape province, which retained its own blood service. Many staff, including myself, have been part of this 21-year journey of SANBS and, like with any family or organisation, there have been both challenges and significant achievements.  A key challenge in the early years was taking into consideration different cultures, practises, procedures and systems, and looking for best practice to develop a roadmap for “One SANBS”.

Significant achievements

These are just some of many efforts we have been involved in over the past 21 years. It has been a journey of challenges and triumphs, but at the heart of it all is a dedicated workforce which enables us to continue contributing to the healthcare sector of this country. Upskilling our staff is a huge priority area. We invest in the continuous development of our people to ensure we create employees fit for the future while we continue to build a sustainable blood service.

 

We remain committed to our mandate of providing trusted blood products and services to all patients at a world class level of cost and quality while innovating new treatments to enhance human healthcare.

 

We will always embrace challenges because we know they make us better and stronger in our resolve.

Significant achievements

These are just some of many efforts we have been involved in over the past 21 years. It has been a journey of challenges and triumphs, but at the heart of it all is a dedicated workforce which enables us to continue contributing to the healthcare sector of this country. Upskilling our staff is a huge priority area. We invest in the continuous development of our people to ensure we create employees fit for the future while we continue to build a sustainable blood service.

 

We remain committed to our mandate of providing trusted blood products and services to all patients at a world class level of cost and quality while innovating new treatments to enhance human healthcare.

 

We will always embrace challenges because we know they make us better and stronger in our resolve.

Operating Context

Covid-19

The Covid-19 pandemic continued to impact on SANBS operations during the 2021/2022 financial year and the past 12 months continued to be challenging. We had to constantly monitor our internal and external environment and be agile in our responses to changing levels of restrictions and infections.

The Omicron variant that led to the 4th wave in November/December 2021 had a significant impact on our operations as a result of a number of staff being off sick and also many blood drives being cancelled. We had to implement restrictive issue (cutback) of Group O blood to preserve stocks during December and early January.

Blood collections

Our Group O blood collections for the year was at 95.7% of target and our apheresis platelet collections was at 107.1% of target. The latter achievement was due to several initiatives that were implemented nationally to increase access to donors. Challenges with the decline in the donor base were addressed with the gradual lifting of restrictions, and the donor panel was increased by almost 50 000 donors over the period June 2021 to May 2022.

The biggest impact is evident in the growth of the youth and the black donor population. The overall recovery in the donor panel is largely due to increased access to schools and businesses, as Covid-19 restrictions were progressively relaxed. I want to thank our regular blood donors once again for continuing to give the gift of life and the many other stakeholders that assist SANBS in sourcing blood drives and promoting blood donations.

Our staff

The Remote Working Policy was implemented in 2021, enabling staff to work remotely where possible for up to three days a week and going to the office for two days. This arrangement has worked well, affording flexibility to staff while ensuring that some time is spent at the office to maintain social cohesion and for teams to interact with one another. The moratorium on the appointment of staff, which had been in place the prior year, was gradually lifted, initially with the appointment of staff on a fixed term basis, followed by permanent appointments for key vacant positions. People development continues to be a key focus area with many opportunities being afforded to staff to study and bursaries also being granted to children of qualifying staff members. This has led to several internal staff being promoted and appointed to senior positions.

Research and Development

Research and Development remains a priority and through the Research, Advisory and Development (RAD) Academy we hosted several online webinars and learning cafés, covering a wide range of scientific and non-scientific topics. These educational sessions are open to internal staff and external stakeholders and have been very well received.

We continued to perform follow-up Covid-19 sero-prevalence studies on our donors to determine the percentage of donors who were exposed to the SARS-CoV-2 virus and developed antibodies. This was extrapolated to the general population and continues to contribute significantly to the public health data in South Africa and globally.

Leveraging technology

A major multi-year project is the implementation of the new Blood Establishment Computer System (BECS) in partnership with our service provider, MAK-SYSTEM. There were some challenges encountered during the year which have now been resolved and the go-live date is planned for April 2023. There will be a number of new innovative features once we go live, the most exciting of which is the mobile donor application which will enable SANBS to improve the donor experience. Our laboratories continue to function well and are all accredited to ISO 15189 standards. The roll-out of new instruments for blood bank automation was implemented in 2021 following an extensive evaluation of available instruments and this roll-out is progressing well, despite some problems in procuring the instruments due to global supply chain challenges.

Operating Context

Covid-19

The Covid-19 pandemic continued to impact on SANBS operations during the 2021/2022 financial year and the past 12 months continued to be challenging. We had to constantly monitor our internal and external environment and be agile in our responses to changing levels of restrictions and infections.

The Omicron variant that led to the 4th wave in November/December 2021 had a significant impact on our operations as a result of a number of staff being off sick and also many blood drives being cancelled. We had to implement restrictive issue (cutback) of Group O blood to preserve stocks during December and early January.

Blood collections

Our Group O blood collections for the year was at 95.7% of target and our apheresis platelet collections was at 107.1% of target. The latter achievement was due to several initiatives that were implemented nationally to increase access to donors. Challenges with the decline in the donor base were addressed with the gradual lifting of restrictions, and the donor panel was increased by almost 50 000 donors over the period June 2021 to May 2022.

The biggest impact is evident in the growth of the youth and the black donor population. The overall recovery in the donor panel is largely due to increased access to schools and businesses, as Covid-19 restrictions were progressively relaxed. I want to thank our regular blood donors once again for continuing to give the gift of life and the many other stakeholders that assist SANBS in sourcing blood drives and promoting blood donations.

Our staff

The Remote Working Policy was implemented in 2021, enabling staff to work remotely where possible for up to three days a week and going to the office for two days. This arrangement has worked well, affording flexibility to staff while ensuring that some time is spent at the office to maintain social cohesion and for teams to interact with one another. The moratorium on the appointment of staff, which had been in place the prior year, was gradually lifted, initially with the appointment of staff on a fixed term basis, followed by permanent appointments for key vacant positions. People development continues to be a key focus area with many opportunities being afforded to staff to study and bursaries also being granted to children of qualifying staff members. This has led to several internal staff being promoted and appointed to senior positions.

Research and Development

Research and Development remains a priority and through the Research, Advisory and Development (RAD) Academy we hosted several online webinars and learning cafés, covering a wide range of scientific and non-scientific topics. These educational sessions are open to internal staff and external stakeholders and have been very well received.

We continued to perform follow-up Covid-19 sero-prevalence studies on our donors to determine the percentage of donors who were exposed to the SARS-CoV-2 virus and developed antibodies. This was extrapolated to the general population and continues to contribute significantly to the public health data in South Africa and globally.

Leveraging technology

A major multi-year project is the implementation of the new Blood Establishment Computer System (BECS) in partnership with our service provider, MAK-SYSTEM. There were some challenges encountered during the year which have now been resolved and the go-live date is planned for April 2023. There will be a number of new innovative features once we go live, the most exciting of which is the mobile donor application which will enable SANBS to improve the donor experience. Our laboratories continue to function well and are all accredited to ISO 15189 standards. The roll-out of new instruments for blood bank automation was implemented in 2021 following an extensive evaluation of available instruments and this roll-out is progressing well, despite some problems in procuring the instruments due to global supply chain challenges.

Highlights for 2021/2022

Highlights for 2021/2022

Sustainability Highlights

Sustainability Highlights

Our People and Culture

Ongoing investment in our staff

We deliver on our purpose and mission through our staff and it is imperative that we continue to maintain a strong focus on staff development, talent management, succession planning, performance management and ensuring overall wellness of staff. Our executives and senior managers participated in an Immersive Leadership course where we worked through a number of business simulations and leadership exercises to gain experience of real-life business situations – this was well received and also assisted in building teamwork and camaraderie amongst the leadership group.

 

Investment in staff development and continuous professional development is something that we are proud of and we continued to offer employees financial assistance to study for degrees/diplomas and qualifications of their choice. Staff have an opportunity to access a number of learning initiatives through our intranet and we have subscribed to Bookboon and Udemy platforms to enable access to an extensive selection of e-books and learning material.

 

Additionally, we partnered with Wits University to offer staff the opportunity to enrol in a number of digital distance learning courses. We continue to provide bursaries to children of our staff to ensure that we play a role in developing leaders of the future. Even though the Covid-19 restrictions were gradually lifted in 2021/2022, SANBS continues to maintain the remote working arrangement with flexible arrangements for office bound staff.

 

Our Occupational Health Department continued to monitor health and wellness of staff and provided significant support to staff who were tested positive for Covid-19. We embarked on a number of workshops and initiatives to promote voluntary vaccinations to minimise risk of SARS-CoV-2 infection.

Outlook/Looking Ahead

Some of the key initiatives/projects looking ahead include:

  • Ensuring that we continue to have an integrated approach as we prepare to implement the new BECS. A key focus area will be change management for staff impacted by the changes.
  • Adapting our business model to the constrained external environment with the aim to carefully manage expenses and keeping tariff increases low.
  • Improving our internal processes with a specific focus on the “Order-to-Collect process” and “Procure-to-Pay process”.
  • Investing in the wellness and development of our staff with a particular focus on work–life balance, strengthening the organisational culture, increasing staff retention and rolling out succession planning initiatives to middle management.
  • Constantly adapting to ensure that we can collect sufficient blood to meet demand and maintain five-days cover. This will include new initiatives to increase the donor base and safeguard good donor health while ensuring that patients receive blood ordered with no cutbacks.
  • Relooking at our platelet product offerings to meet the demand for platelets.
  • Collaborating locally, regionally and globally in the spheres of research, innovation and blood safety.
  • Increasing focus on our stakeholders/regulators to build long-term partnerships.
  • Refining the iHEALTh strategy to ensure a long-term focus beyond 2024.
  • Achieving JACIE accreditation for stem cell collection and processing centres.
  • Continuing with the implementation of the Drone programme and roll out of smart fridges.
  • Implementing ISO 9001 Quality systems in our Support Service departments.

Our People and Culture

Ongoing investment in our staff

We deliver on our purpose and mission through our staff and it is imperative that we continue to maintain a strong focus on staff development, talent management, succession planning, performance management and ensuring overall wellness of staff. Our executives and senior managers participated in an Immersive Leadership course where we worked through a number of business simulations and leadership exercises to gain experience of real-life business situations – this was well received and also assisted in building teamwork and camaraderie amongst the leadership group.

 

Investment in staff development and continuous professional development is something that we are proud of and we continued to offer employees financial assistance to study for degrees/diplomas and qualifications of their choice. Staff have an opportunity to access a number of learning initiatives through our intranet and we have subscribed to Bookboon and Udemy platforms to enable access to an extensive selection of e-books and learning material.

 

Additionally, we partnered with Wits University to offer staff the opportunity to enrol in a number of digital distance learning courses. We continue to provide bursaries to children of our staff to ensure that we play a role in developing leaders of the future. Even though the Covid-19 restrictions were gradually lifted in 2021/2022, SANBS continues to maintain the remote working arrangement with flexible arrangements for office bound staff.

 

Our Occupational Health Department continued to monitor health and wellness of staff and provided significant support to staff who were tested positive for Covid-19. We embarked on a number of workshops and initiatives to promote voluntary vaccinations to minimise risk of SARS-CoV-2 infection.

Outlook/
Looking
Ahead

Some of the key initiatives/projects looking ahead include:

  • Ensuring that we continue to have an integrated approach as we prepare to implement the new BECS. A key focus area will be change management for staff impacted by the changes.
  • Adapting our business model to the constrained external environment with the aim to carefully manage expenses and keeping tariff increases low.
  • Improving our internal processes with a specific focus on the “Order-to-Collect process” and “Procure-to-Pay process”.
  • Investing in the wellness and development of our staff with a particular focus on work–life balance, strengthening the organisational culture, increasing staff retention and rolling out succession planning initiatives to middle management.
  • Constantly adapting to ensure that we can collect sufficient blood to meet demand and maintain five-days cover. This will include new initiatives to increase the donor base and safeguard good donor health while ensuring that patients receive blood ordered with no cutbacks.
  • Relooking at our platelet product offerings to meet the demand for platelets.
  • Collaborating locally, regionally and globally in the spheres of research, innovation and blood safety.
  • Increasing focus on our stakeholders/regulators to build long-term partnerships.
  • Refining the iHEALTh strategy to ensure a long-term focus beyond 2024.
  • Achieving JACIE accreditation for stem cell collection and processing centres.
  • Continuing with the implementation of the Drone programme and roll out of smart fridges.
  • Implementing ISO 9001 Quality systems in our Support Service departments.

Conclusion and Appreciation

In celebrating our 21-year anniversary as the South African National Blood Service, I want to express my heartfelt thanks to all the staff, current and past, that have contributed significantly to ensuring the continued success of SANBS in delivering on our purpose and mission. Without your passion, commitment and loyalty we would not have achieved what we can today be proud of when we reflect on these past 21 years. I want to particularly thank the members of my Executive team for all their support during the year and filling in for me when I was away from the office.

 

The SANBS Board has always played a key role in supporting our strategy and ensuring a strong governance framework. I want to express my sincere appreciation and thanks to all the Board and Committee members for your leadership and support over this past year, it is sincerely appreciated.

 

Our dedicated and regular blood donors remain the cornerstone of ensuring that SANBS can fulfil its mandate. Even though we had a very challenging year with Covid-19 restrictions and limited access to blood drives at work places, our voluntary donors remained steadfast in their commitment to donate, and despite being inconvenienced and having to travel to our donor centres, they continued to heed the call to donate.  I also want to express my gratitude and thanks to our volunteers that serve on the various Branch and Zone Donor committees. They play an important role in helping our staff with campaigns and  to grow our donor base and I thank you for your time and commitment.

 

Finally, we have a number of other important stakeholders that play a key role, on a daily basis, in ensuring that SANBS functions effectively. I also want to express my appreciation to all of you for the role you play in ensuring that we can save and improve the lives of hundreds of thousands of patients annually.

Conclusion and Appreciation

In celebrating our 21-year anniversary as the South African National Blood Service, I want to express my heartfelt thanks to all the staff, current and past, that have contributed significantly to ensuring the continued success of SANBS in delivering on our purpose and mission. Without your passion, commitment and loyalty we would not have achieved what we can today be proud of when we reflect on these past 21 years. I want to particularly thank the members of my Executive team for all their support during the year and filling in for me when I was away from the office.

 

The SANBS Board has always played a key role in supporting our strategy and ensuring a strong governance framework. I want to express my sincere appreciation and thanks to all the Board and Committee members for your leadership and support over this past year, it is sincerely appreciated.

 

Our dedicated and regular blood donors remain the cornerstone of ensuring that SANBS can fulfil its mandate. Even though we had a very challenging year with Covid-19 restrictions and limited access to blood drives at work places, our voluntary donors remained steadfast in their commitment to donate, and despite being inconvenienced and having to travel to our donor centres, they continued to heed the call to donate.  I also want to express my gratitude and thanks to our volunteers that serve on the various Branch and Zone Donor committees. They play an important role in helping our staff with campaigns and  to grow our donor base and I thank you for your time and commitment.

 

Finally, we have a number of other important stakeholders that play a key role, on a daily basis, in ensuring that SANBS functions effectively. I also want to express my appreciation to all of you for the role you play in ensuring that we can save and improve the lives of hundreds of thousands of patients annually.